Myeloma

Showing 26 - 50 of 133

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloma Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Myeloma
  • Hyperbaric oxygen
  • Rochester, New York
    James P. Wilmot Cancer Center at University of Rochester Medical
May 5, 2022

Dual-Energy Computed Tomography for Improving Imaging Assessment

Not yet recruiting
  • Myeloma
  • Whole Body MRI
  • (no location specified)
Apr 25, 2022

Myeloma Trial in La Jolla, Orange, Sacramento (Clarithromycin, Dexamethasone, Ixazomib Citrate)

Active, not recruiting
  • Myeloma
  • La Jolla, California
  • +2 more
Mar 14, 2022

Myeloma, MGUS Trial in Rochester (Infusion of 13-Carbon labeled Glutamine)

Recruiting
  • Myeloma
  • MGUS
  • Infusion of 13-Carbon labeled Glutamine
  • Rochester, Minnesota
    Mayo Clinic
Feb 10, 2022

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

tHe Early Recognition of Febrile Neutropenia in Haematological

Recruiting
  • Haematological Malignancy
  • +4 more
  • TempTraq temperature monitor
  • Wellington, New Zealand
    Malaghan Institute of Medical Research
Jan 10, 2022

Myeloma Trial in Sutton, London (Machine Learning (ML))

Active, not recruiting
  • Myeloma
  • Machine Learning (ML)
  • Sutton, Surrey, United Kingdom
  • +2 more
Jan 7, 2022

Myeloma Trial in France (18F-Fludarabine)

Not yet recruiting
  • Myeloma
  • Angers, France
  • +6 more
Dec 24, 2021

Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloma Trial in Bergamo (Patient registry)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Patient registry
  • Bergamo, Italy
    Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
Dec 22, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)

Not yet recruiting
  • Monoclonal Gammopathy
  • +2 more
  • DKK1
  • Cleveland, Ohio
  • +1 more
Nov 29, 2021

Myeloma Trial in Houston (drug, other, behavioral)

Completed
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 22, 2021

Hematologic Malignancy, MDS, Acute Myeloid Leukemia Trial in Providence (Transfusion support)

Recruiting
  • Hematologic Malignancy
  • +5 more
  • Transfusion support
  • Providence, Rhode Island
    Rhode Island Hospital
Nov 4, 2021

Myeloma, Lymphoma, Autologous Transplant Trial in Angers, Le Mans (Adapted Physical Activity)

Recruiting
  • Myeloma
  • +2 more
  • Adapted Physical Activity
  • Angers, France
  • +1 more
Oct 7, 2021

Myeloma Trial in Netherlands (nivolumab-daratumumab, nivolumab-daratumumab with low-dose cyclophosphamide)

Active, not recruiting
  • Myeloma
  • Arnhem, Ge, Netherlands
  • +8 more
Oct 5, 2021

Changing Over Time of Ascorbic Acid After Chemotherapy

Active, not recruiting
  • Leukemia (Both ALL and AML)
  • +2 more
  • blood withdrawn
  • Maastricht, Limburg, Netherlands
    MUMC+
Sep 23, 2021

Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)

Recruiting
  • Myeloma
  • Multiple Myeloma
  • Chicago, Illinois
    The University of Chicago
Sep 15, 2021

Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

Recruiting
  • Myeloma
  • Copenhagen, Denmark
  • +3 more
Sep 15, 2021

Myeloma Trial in Chicago (drug, procedure, device)

Active, not recruiting
  • Myeloma
  • Chicago, Illinois
    University of Chicago
Sep 14, 2021

MRI in Multiple Myeloma: Analysis of Axial Skeleton Versus Whole

Terminated
  • Myeloma
  • MRI
  • Montpellier, France
  • +1 more
Aug 3, 2021

Lymphoma, Myeloma, High-dose Chemo Trial in Berne (Pedometer-based activity monitoring after ASCT)

Recruiting
  • Lymphoma
  • +3 more
  • Pedometer-based activity monitoring after ASCT
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Jul 29, 2021

The Development and Pilot Testing ofNew MR Imaging Protocol to

Completed
  • Myeloma
  • +2 more
  • Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
  • +2 more
  • Oxford, Oxfordshire, United Kingdom
    Churchill Hospital
Feb 4, 2021

Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)

Unknown status
  • Myeloma
  • +2 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020